Options Medical Weight Loss (Chicago, Illinois)

Clinic Introduction

Options Medical Weight Loss operates in Chicago, Illinois, under the leadership of CEO Jeremy Castle, delivering physician-supervised weight management programs that integrate prescription peptide therapy with structured nutritional guidance and behavioral coaching. The clinic holds LegitScript certification, a third-party verification standard that confirms adherence to healthcare compliance protocols and legitimate prescribing practices. With a 4.7-star rating across 531 Google reviews, Options Medical Weight Loss has established a track record in the Chicago metropolitan area for evidence-based obesity treatment that extends beyond short-term dieting. The clinic's peptide therapy protocol centers on tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Tirzepatide functions by enhancing insulin secretion in response to meals, suppressing glucagon release, and slowing gastric emptying, which collectively reduce appetite and caloric intake. Options Medical Weight Loss prescribes tirzepatide as part of a comprehensive program that includes baseline metabolic assessments, body composition analysis, and ongoing dosage titration based on patient tolerance and weight loss velocity. The clinic also addresses hormone health concerns that frequently accompany weight gain, including thyroid dysfunction, insulin resistance, and sex hormone imbalances, integrating laboratory evaluation and corrective interventions when clinically indicated. Jeremy Castle leads a clinical team that includes licensed physicians who conduct initial consultations, review medical histories, and authorize peptide prescriptions in accordance with Illinois medical board regulations. Each patient undergoes a structured intake process that evaluates contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. The medical team monitors patients through regular follow-up visits—available both in-person at the Chicago clinic and via telehealth for Illinois residents—to assess treatment response, manage side effects such as nausea or gastrointestinal discomfort, and adjust medication protocols as needed. The clinic's approach emphasizes patient education on the mechanisms of GLP-1 and GIP agonism, realistic weight loss timelines, and the importance of concurrent lifestyle modification to sustain metabolic improvements beyond the active treatment phase. Patients at Options Medical Weight Loss receive individualized meal planning, exercise recommendations tailored to current fitness levels, and access to health coaches who provide accountability between physician visits. The program structure includes weekly or biweekly check-ins during the initial titration phase, with frequency adjusted based on individual progress and stability. The clinic dispenses tirzepatide through partner pharmacies that compound or supply FDA-approved formulations, ensuring medication quality and proper cold-chain handling. Patients are instructed on subcutaneous self-injection technique, injection site rotation, and recognition of adverse effects that warrant immediate medical consultation. The clinic also provides resources on managing common side effects, including dietary strategies to minimize nausea and guidance on hydration and electrolyte balance during periods of reduced caloric intake. Options Medical Weight Loss offers both in-person consultations at its Chicago location and telehealth appointments for patients throughout Illinois, expanding access to medically supervised weight loss for individuals unable to travel to the clinic regularly. Telehealth visits include video consultations with prescribing physicians, digital submission of progress photos and weight logs, and electronic prescription transmission to the patient's preferred pharmacy. The clinic's LegitScript certification provides assurance that its telemedicine practices comply with state and federal regulations governing remote prescribing of controlled and high-risk medications. For patients seeking hormone optimization alongside weight management, the clinic coordinates thyroid panel testing, sex hormone evaluation, and metabolic marker tracking, addressing the multifactorial contributors to weight gain and metabolic dysfunction that often require integrated treatment beyond peptide therapy alone. The scope of services recorded for this clinic covers testosterone optimization for men experiencing low energy, reduced libido, changes in body composition, or sleep and mood shifts; medically supervised weight management, pairing prescription options with nutrition and lifestyle guidance rather than prescription alone. Practical details recorded for this location: the phone number on file is (773) 572-1863; the published hours are Friday: Closed; Monday: 8 AM-5 PM; Sunday: Closed; Tuesday: Closed; Saturday: Closed; Thursday: 8 AM-4 PM; Wednesday: Closed; the clinic website on file is https://optionsmedicalweightloss.com/locations/illinois/bucktown. Patients travelling to Chicago should confirm hours before a trip, because appointment times and operating schedules differ between locations in a multi-site practice. This entry covers the Chicago location. Hormone and peptide therapy is a medical decision that should follow an evaluation and a discussion with a qualified clinician. Results vary between individuals, and no outcome is guaranteed. This profile is informational and does not replace medical advice.